
About Cibeles
Cibeles is a Healthcare company based in Pune (India). Pharmaceutical manufacturing, distribution, and employee-focused services in India. It operates in the Healthcare and Transportation, Automotive & Logistics sectors. Its Indian entity Cibeles Pharmaceuticals Private Limited reported revenue of βΉ27.15 Cr. Cibeles offers products and services including Pharmaceutical Products and Distribution Services. Its focus areas include Pharmaceuticals, Drug Manufacturing, Women's Health Products and Distribution.
Company details
Cibeles Pharmaceuticals Private Limited is observed as an organization that prioritizes people in its operations, fostering a caring and inclusive culture where employees, referred to as Cibeleans, are provided opportunities for growth and meaningful work. Relationships with trade partners are built to ensure sustainable collaborations for patient access to solutions. Innovation is pursued to expand offerings, benefiting stakeholders and contributing to broader societal advancement. The company is noted for its commitment to womens health and internal achievements, operating from Pune, India, with a focus on ethical practices and career development.
- Headquarters Pune, India
- SectorsHealthcareTransportation, Automotive & Logistics
- Emailβ’β’β’β’β’β’β’β’
- Website cibeles.com
- Social LinkedIn
- Legal Name Cibeles Pharmaceuticals Private Limited
- Date of Incorporation 03 May, 2019
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹27.15 Cr
FY 2025 · +48% YoY
- Net Loss-₹9.15 Cr
FY 2025 · -34% margin
- EBITDA-₹9.20 Cr
FY 2025 · -34% margin
Associated legal entities of Cibeles
Cibeles operates through Cibeles Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Cibeles Pharmaceuticals Private Limited CIN U24100MH2019PTC379982 | Active | 03 May 2019 | Mumbai, Maharashtra | ₹27.2 Cr | 4 | View details |
Products & Services of Cibeles
Cibeles offers a comprehensive portfolio of products and services, including Pharmaceutical Products and Distribution Services.
Pharmaceutical products are developed and distributed by Cibeles to address women's health and other needs, ensuring access through partnerships.
Distribution services are managed by Cibeles to facilitate collaborations with trade partners for timely delivery of solutions.
Board of directors of Cibeles Pharmaceuticals Private Limited (Cibeles)
Cibeles Pharmaceuticals Private Limited is the primary company behind Cibeles. The board of Cibeles Pharmaceuticals Private Limited currently have 3 directors; the longest-serving is Sainath Vramarathnam Iyer, appointed in 2019. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sainath Vramarathnam Iyer DIN 08590081 | Director | 22 Oct 2019 | 7 yrs | Cibeles Pharmaceuticals Private Limited |
| Trushit Pramodray Mehta DIN 06439479 | Nominee Director | 03 Mar 2020 | 6 yrs 8 mo | Cibeles Pharmaceuticals Private Limited |
| Dheer Dharmesh Shah DIN 07937075 | Nominee Director | 03 Mar 2020 | 6 yrs 8 mo | Cibeles Pharmaceuticals Private Limited |
Financials of Cibeles
Figures of Cibeles Pharmaceuticals Private Limited, the primary company behind Cibeles, for FY 2025. Revenue was ₹27.15 Cr (+48% year on year). Net loss was -₹9.15 Cr (-34% margin). EBITDA was -₹9.20 Cr (-34% margin). Revenue has grown at a compounded annual rate of +35% over three years and +109% over five years.
- ₹27.15 CrRevenue · FY 2025 · +48% YoY
- -₹9.15 CrNet loss · -34% margin
- -₹9.20 CrEBITDA · -34% margin
- ₹22.32 CrPaid-up capital
- +35%Revenue CAGR, 3 years
- +109%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Cibeles Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Cibeles
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Cibeles
Cibeles is headquartered in Pune, India. It is registered at Pune, Maharashtra, India.
The primary company behind Cibeles, Cibeles Pharmaceuticals Private Limited, reported revenue of βΉ27.15 Cr for FY 2025, up 48% year on year.
Cibeles Pharmaceuticals Private Limited is observed as an organization that prioritizes people in its operations, fostering a caring and inclusive culture where employees, referred to as Cibeleans, are provided opportunities for growth and meaningful work. Relationships with trade partners are built to ensure sustainable collaborations for patient access to solutions. Innovation is pursued to expand offerings, benefiting stakeholders and contributing to broader societal advancement. The company is noted for its commitment to womens health and internal achievements, operating from Pune, India, with a focus on ethical practices and career development.
Cibeles offers Pharmaceutical Products and Distribution Services.
Cibeles operates through Cibeles Pharmaceuticals Private Limited.
The legal entities of Cibeles currently have 3 directors, including Trushit Pramodray Mehta, Sainath Vramarathnam Iyer, Dheer Dharmesh Shah.